Center for Cancer Nanotechnology Excellence Focused on Therapy Response

Faculty

Garry Nolan, Ph.D. Project Leader: Project 3 Associate Professor of Microbiology and Immunology, and of Molecular Pharmacology (Stanford) Director Stanford NHLBI Proteomics Center Stanford School of Medicine Dept. of Microbiology and Immunology Baxter Lab for Genetic Pharmacology Stanford, CA 94305 Phone: (650) 725-7002 Fax: (650) 723-2383 Email: gnolan@stanford.edu

Project Leader: Project 3, Associate Professor of Microbiology and Immunology, and of Molecular Pharmacology (Stanford)
Dr. Nolan is currently the Chair of the Fluorescence Activated Cell Sorting (FACS) Shared Facility oversight committee and Director of the Stanford NHLBI Proteomics Center, focusing on proteomic analysis of autoimmune diseases. He has been actively leading efforts in new methodology to study complex networks of interacting proteins using phospho-specific antibodies. Most recently he has teamed up with Intel Inc. to utilize Raman Quantum Dots for multiplexing strategies to study cancer biology, since the technology affords the possibility to go beyond the limits of conventional sensitivity of fluorescence-based approaches for single cell analysis. In addition, the technology points in the direction of being able to use COINS and Raman detection methods to multiplex signature elements well beyond the current limitations of 15-20 proteins measured per cell. Dr. Nolan's long history in the development and open dissemination of novel and powerful technologies is supportive of his successful participation in this CCNE-TR.

[ Back ]